Literature DB >> 28389813

Plasma neutrophil gelatinase-associated lipocalin is associated with iron status in anemic patients with pre-dialysis chronic kidney disease.

Il Young Kim1,2, Joo Hui Kim1,2, Dong Won Lee1,2, Soo Bong Lee3,4, Harin Rhee1,5, Sang Heon Song1,5, Eun Young Seong1,5, Ihm Soo Kwak1,5.   

Abstract

BACKGROUND: Iron deficiency anemia is common in patients with chronic kidney disease (CKD). Neutrophil gelatinase-associated lipocalin (NGAL), a biomarker of acute kidney injury, is known to be associated with iron metabolism. We investigated whether plasma NGAL level is associated with iron status in pre-dialysis CKD patients with anemia.
METHODS: This study included 419 patients who had anemia. The subjects were into categorized into a pre-dialysis group (estimated glomerular filtration rate [eGFR] <60 ml/min/1.73 m2, n = 288) and a non-CKD group (eGFR >60 ml/min/1.73 m2, n = 131). The associations between plasma NGAL and iron status (serum ferritin and transferrin saturation [TSAT]), eGFR, albumin, uric acid, total cholesterol, calcium, phosphate, and C-reactive protein (CRP) were assessed.
RESULTS: In non-CKD group, plasma NGAL was not associated with any baseline variables including iron indices (TSAT and serum ferritin). In pre-dialysis group, univariate analysis showed plasma NGAL correlated with eGFR, CRP, TSAT, and serum ferritin. In multivariate analysis, plasma NGAL was independently associated with TSAT. However, serum ferritin lost its association with plasma NGAL. In ROC analysis for identifying iron deficiency, the plasma NGAL (best cut-off value ≤394 ng/ml) was superior to the serum ferritin (suggested cut-off value ≤500 ng/ml) in both sensitivity and specificity.
CONCLUSIONS: Plasma NGAL is associated with iron status in anemic patients with pre-dialysis CKD. Further studies are needed to demonstrate the role of plasma NGAL in assessing the iron deficiency and in guiding the iron therapy for pre-dialysis CKD patients.

Entities:  

Keywords:  Anemia; Chronic kidney disease; Iron deficiency; Neutrophil gelatinase-associated lipocalin

Mesh:

Substances:

Year:  2017        PMID: 28389813     DOI: 10.1007/s10157-017-1409-6

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  24 in total

Review 1.  Neutrophil gelatinase-associated lipocalin and hepcidin: what do they have in common and is there a potential interaction?

Authors:  Jolanta Malyszko; Vladimir Tesar; Iain C Macdougall
Journal:  Kidney Blood Press Res       Date:  2010-05-26       Impact factor: 2.687

Review 2.  Anemia of chronic disease.

Authors:  Guenter Weiss; Lawrence T Goodnough
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

3.  The conundrum of serum ferritin measurement in patients with chronic kidney disease.

Authors:  Der-Cherng Tarng
Journal:  Nat Clin Pract Nephrol       Date:  2008-12-09

Review 4.  Iron management in end-stage renal disease.

Authors:  S Fishbane; J K Maesaka
Journal:  Am J Kidney Dis       Date:  1997-03       Impact factor: 8.860

5.  Uses and interpretation of iron studies in patients on chronic dialysis.

Authors:  Anatole Besarab; Lynda Szczech
Journal:  Semin Dial       Date:  2014-07-01       Impact factor: 3.455

6.  Evaluation of serum NGAL and hepcidin levels in chronic kidney disease patients.

Authors:  Esin Avci Çiçek; Simin Rota; Belda Dursun; Emine Kavalci
Journal:  Ren Fail       Date:  2015-12-01       Impact factor: 2.606

7.  Anemia: an early complication of chronic renal insufficiency.

Authors:  W H Kazmi; A T Kausz; S Khan; R Abichandani; R Ruthazer; G T Obrador; B J Pereira
Journal:  Am J Kidney Dis       Date:  2001-10       Impact factor: 8.860

8.  The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition.

Authors:  David H Goetz; Margaret A Holmes; Niels Borregaard; Martin E Bluhm; Kenneth N Raymond; Roland K Strong
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

9.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

10.  Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.

Authors:  Davide Bolignano; Antonio Lacquaniti; Giuseppe Coppolino; Valentina Donato; Susanna Campo; Maria Rosaria Fazio; Giacomo Nicocia; Michele Buemi
Journal:  Clin J Am Soc Nephrol       Date:  2009-01-28       Impact factor: 8.237

View more
  4 in total

Review 1.  Iron Deficiency in Chronic Kidney Disease: Updates on Pathophysiology, Diagnosis, and Treatment.

Authors:  Elizabeth Katherine Batchelor; Pinelopi Kapitsinou; Pablo E Pergola; Csaba P Kovesdy; Diana I Jalal
Journal:  J Am Soc Nephrol       Date:  2020-02-10       Impact factor: 10.121

2.  β 2-Microglobulin and Neutrophil Gelatinase-Associated Lipocalin, Potential Novel Urine Biomarkers in Periodontitis: A Cross-Sectional Study in Japanese.

Authors:  Mayuka Nakajima; Michihiro Hosojima; Koichi Tabeta; Sayuri Miyauchi; Miki Yamada-Hara; Naoki Takahashi; Haruna Miyazawa; Yumi Matsuda-Matsukawa; Keisuke Sato; Noriko Sugita; Yasutaka Komatsu; Tomomi Ishikawa; Kazuhiro Akiishi; Kazuhisa Yamazaki; Kiminori Kato; Akihiko Saito; Hiromasa Yoshie
Journal:  Int J Dent       Date:  2019-03-20

Review 3.  Biomarkers of iron metabolism in chronic kidney disease.

Authors:  Glogowski Tomasz; Wojtaszek Ewa; Malyszko Jolanta
Journal:  Int Urol Nephrol       Date:  2020-10-06       Impact factor: 2.370

4.  Lipocalin 2 stimulates bone fibroblast growth factor 23 production in chronic kidney disease.

Authors:  Guillaume Courbon; Connor Francis; Claire Gerber; Samantha Neuburg; Xueyan Wang; Emily Lynch; Tamara Isakova; Jodie L Babitt; Myles Wolf; Aline Martin; Valentin David
Journal:  Bone Res       Date:  2021-08-02       Impact factor: 13.567

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.